The pharmaceutical industry's shift towards digital engagement has underscored the need for more personalized and impactful communication strategies. Highp addresses this demand by seamlessly integrating with Veeva Approved Email, enabling the inclusion of personalized video messages without the need for complex IT integrations.
Enhancing Engagement Through Personalization
Highp allows pharmaceutical representatives to record personalized video messages that are embedded into Veeva Approved Emails. These videos are transformed into GIF animations within the email, providing a dynamic and engaging preview that encourages recipients to interact with the content. Upon clicking, HCPs are directed to a personal message featuring the full video and additional rich media content, all compliant with industry regulations. This message can be fully customized.
Streamlined Implementation
One of Highp's key advantages is its ease of implementation. By adding a few lines of code to existing email templates, pharmaceutical companies can enhance their communications without overhauling their current systems. This plug-and-play approach means no additional apps or integrations are necessary, allowing for rapid deployment and minimal disruption .
Proven Results
The integration of Highp with Veeva Approved Email has demonstrated significant improvements in engagement metrics. In a pilot program conducted by a leading pharmaceutical company, emails incorporating Highp's personalized video content achieved an up to 92% open rate, with 45% of recipients viewing the embedded videos. These figures represent a substantial increase compared to traditional email campaigns
Conclusion
Highp's integration with Veeva Approved Email represents a significant advancement in pharmaceutical marketing, combining personalization, compliance, and ease of use to deliver more effective communications to HCPs. As the industry continues to evolve, solutions like Highp are poised to play a crucial role in enhancing digital engagement strategies.
Why Extending Veeva Approved Email with Highp is Worth It
Pharmaceutical companies using Veeva Approved Email already benefit from compliant, template-driven communications, but combining it with Highp takes your customer engagement to the next level. Here’s why:
Interactivity That Goes Beyond Simple Email
Highp transforms passive, read-only emails into interactive experiences. Instead of just sending text or images, reps can add interactive video messages, surveys, consent forms, and other dynamic blocks that drive two-way communication. This boosts not only engagement but also the quality of data and feedback you gather from HCPs.
Speed: Build from Ready-Made Interactive Blocks
With Highp, you don’t need to start from scratch. Everything — from video embeds to consent capture — is prebuilt into modular, interactive blocks. Marketers and reps can design, customize, and deploy campaigns much faster, without relying heavily on IT or external developers. What used to take weeks can now be done in days or even hours.
Over 25 Pharma-Dedicated Features (No IT Required)
To build similar functionality internally, your IT team would need to write, test, and maintain countless tools — but Highp already offers them out of the box. Examples include:
- Advanced consent management, customizable per campaign.
- Video content blocks with engagement features like “play only once” or limited-time access for compliance.
- Interactive call-to-action modules, feedback forms, and analytics tools.
This means you can launch sophisticated campaigns without worrying about backend development or regulatory headaches.
Automation: Less Work, More Impact
Highp takes care of many manual tasks automatically. It generates animated GIF previews for emails, personalizes content per recipient, and optimizes video delivery — all without requiring you to run additional programs or tools. This reduces operational burden and ensures your campaigns look polished and professional every time.